Evaluation of Possible Carcinogenic Risk to Humans Based on Liver Tumors in Rodent Assays:The Two-Year Bioassay Is No Longer Necessary

Research output: Contribution to journalReview article

68 Citations (Scopus)

Abstract

The two-year rodent bioassay remains the mainstay for carcinogenicity testing, although numerous difficulties have been identified. Fundamentally, a chemical can increase the risk of cancer (1) by damaging DNA directly (DNA reactive) or (2) indirectly by increasing the number of DNA replications (non–DNA reactive). Mechanistic research has identified numerous precursor lesions in the sequence of key events necessary for neoplasia development. Based on these concepts, the author has proposed a short-term (thirteen-week) assay for screening for carcinogenic potential based on a mode of action analysis and on readily available, identifiable preneoplastic changes. A screening assay that detects all potential rodent hepatocarcinogens has been previously identified (Toxicol Pathol 32 [2004], 393–401) including increased liver weight, hepatocellular necrosis, hypertrophy, and cytomegaly. Labeling index for DNA replication might supply additional support. These markers have high sensitivity but low specificity. However, most chemicals can be appropriately classified as to their mode(s) of action for hepatocarcinogenesis with follow-up mechanistic studies, and a rational evaluation of their relevance to humans can be made. A similar process can be envisioned for other tissues for evaluation for carcinogenic potential.

Original languageEnglish (US)
Pages (from-to)487-501
Number of pages15
JournalToxicologic Pathology
Volume38
Issue number3
DOIs
StatePublished - Apr 2010

Fingerprint

Bioassay
DNA Replication
Biological Assay
Liver
Tumors
Rodentia
Assays
DNA
Hypertrophy
Neoplasms
Screening
Necrosis
Weights and Measures
Sensitivity and Specificity
Research
Labeling
Tissue
Testing

Keywords

  • PPARα agonists
  • cytotoxicity
  • estrogen
  • genotoxicity
  • mitogenesis
  • phenobarbital
  • regeneration

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Biology
  • Toxicology
  • Cell Biology

Cite this

@article{3d146ab9a49543958b02bd80e10016b2,
title = "Evaluation of Possible Carcinogenic Risk to Humans Based on Liver Tumors in Rodent Assays:The Two-Year Bioassay Is No Longer Necessary",
abstract = "The two-year rodent bioassay remains the mainstay for carcinogenicity testing, although numerous difficulties have been identified. Fundamentally, a chemical can increase the risk of cancer (1) by damaging DNA directly (DNA reactive) or (2) indirectly by increasing the number of DNA replications (non–DNA reactive). Mechanistic research has identified numerous precursor lesions in the sequence of key events necessary for neoplasia development. Based on these concepts, the author has proposed a short-term (thirteen-week) assay for screening for carcinogenic potential based on a mode of action analysis and on readily available, identifiable preneoplastic changes. A screening assay that detects all potential rodent hepatocarcinogens has been previously identified (Toxicol Pathol 32 [2004], 393–401) including increased liver weight, hepatocellular necrosis, hypertrophy, and cytomegaly. Labeling index for DNA replication might supply additional support. These markers have high sensitivity but low specificity. However, most chemicals can be appropriately classified as to their mode(s) of action for hepatocarcinogenesis with follow-up mechanistic studies, and a rational evaluation of their relevance to humans can be made. A similar process can be envisioned for other tissues for evaluation for carcinogenic potential.",
keywords = "PPARα agonists, cytotoxicity, estrogen, genotoxicity, mitogenesis, phenobarbital, regeneration",
author = "Cohen, {Samuel Monroe}",
year = "2010",
month = "4",
doi = "10.1177/0192623310363813",
language = "English (US)",
volume = "38",
pages = "487--501",
journal = "Toxicologic Pathology",
issn = "0192-6233",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - Evaluation of Possible Carcinogenic Risk to Humans Based on Liver Tumors in Rodent Assays:The Two-Year Bioassay Is No Longer Necessary

AU - Cohen, Samuel Monroe

PY - 2010/4

Y1 - 2010/4

N2 - The two-year rodent bioassay remains the mainstay for carcinogenicity testing, although numerous difficulties have been identified. Fundamentally, a chemical can increase the risk of cancer (1) by damaging DNA directly (DNA reactive) or (2) indirectly by increasing the number of DNA replications (non–DNA reactive). Mechanistic research has identified numerous precursor lesions in the sequence of key events necessary for neoplasia development. Based on these concepts, the author has proposed a short-term (thirteen-week) assay for screening for carcinogenic potential based on a mode of action analysis and on readily available, identifiable preneoplastic changes. A screening assay that detects all potential rodent hepatocarcinogens has been previously identified (Toxicol Pathol 32 [2004], 393–401) including increased liver weight, hepatocellular necrosis, hypertrophy, and cytomegaly. Labeling index for DNA replication might supply additional support. These markers have high sensitivity but low specificity. However, most chemicals can be appropriately classified as to their mode(s) of action for hepatocarcinogenesis with follow-up mechanistic studies, and a rational evaluation of their relevance to humans can be made. A similar process can be envisioned for other tissues for evaluation for carcinogenic potential.

AB - The two-year rodent bioassay remains the mainstay for carcinogenicity testing, although numerous difficulties have been identified. Fundamentally, a chemical can increase the risk of cancer (1) by damaging DNA directly (DNA reactive) or (2) indirectly by increasing the number of DNA replications (non–DNA reactive). Mechanistic research has identified numerous precursor lesions in the sequence of key events necessary for neoplasia development. Based on these concepts, the author has proposed a short-term (thirteen-week) assay for screening for carcinogenic potential based on a mode of action analysis and on readily available, identifiable preneoplastic changes. A screening assay that detects all potential rodent hepatocarcinogens has been previously identified (Toxicol Pathol 32 [2004], 393–401) including increased liver weight, hepatocellular necrosis, hypertrophy, and cytomegaly. Labeling index for DNA replication might supply additional support. These markers have high sensitivity but low specificity. However, most chemicals can be appropriately classified as to their mode(s) of action for hepatocarcinogenesis with follow-up mechanistic studies, and a rational evaluation of their relevance to humans can be made. A similar process can be envisioned for other tissues for evaluation for carcinogenic potential.

KW - PPARα agonists

KW - cytotoxicity

KW - estrogen

KW - genotoxicity

KW - mitogenesis

KW - phenobarbital

KW - regeneration

UR - http://www.scopus.com/inward/record.url?scp=77952478228&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952478228&partnerID=8YFLogxK

U2 - 10.1177/0192623310363813

DO - 10.1177/0192623310363813

M3 - Review article

C2 - 20215581

AN - SCOPUS:77952478228

VL - 38

SP - 487

EP - 501

JO - Toxicologic Pathology

JF - Toxicologic Pathology

SN - 0192-6233

IS - 3

ER -